Mapping the specific cytoprotective interaction of humanin with the pro-apoptotic protein bid

Chemical Biology and Drug Design

Volumn 70, Issue 5, 2007, Pages 383-392

  Choi, Jungyuen ^a   Zhai, Dayong ^a   Zhou, Xin ^a   Satterthwait, Arnold ^a   Reed, John C ^a   Marassi, Francesca M ^a  

^a BURNHAM INSTITUTE   (United States)

Author keywords

Apoptosis; Bcl 2; BH3; Bid; Chemical shift mapping; Cytoprotection; Humanin; Nuclear magnetic resonance; Peptide

Indexed keywords

BH3 PROTEIN; BIM PROTEIN; HUMANIN; PROTEIN BAX; PROTEIN BCL 2; PROTEIN BID;

APOPTOSIS; ARTICLE; BINDING SITE; CELL DEATH; CELL PROTECTION; CONTROLLED STUDY; CYTOTOXICITY; DRUG MECHANISM; DRUG SYNTHESIS; HUMAN; NUCLEAR MAGNETIC RESONANCE; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN DOMAIN; PROTEIN INTERACTION; PROTEIN LOCALIZATION; PROTON NUCLEAR MAGNETIC RESONANCE;

AMINO ACID SEQUENCE; ANIMALS; APOPTOSIS; APOPTOSIS REGULATORY PROTEINS; BCL-2-ASSOCIATED X PROTEIN; BH3 INTERACTING DOMAIN DEATH AGONIST PROTEIN; CELL DEATH; CONSERVED SEQUENCE; HUMANS; INTRACELLULAR SIGNALING PEPTIDES AND PROTEINS; MAGNETIC RESONANCE SPECTROSCOPY; MEMBRANE PROTEINS; MICE; MODELS, MOLECULAR; MOLECULAR SEQUENCE DATA; PROTEIN CONFORMATION; PROTO-ONCOGENE PROTEINS; SEQUENCE ALIGNMENT; SEQUENCE HOMOLOGY, AMINO ACID;

EID: 35348952538     PISSN: 17470277     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1747-0285.2007.00576.x     Document Type: Article

References (51)

1. Green D.R., Reed J.C. (1998) Mitochondria and apoptosis. Science 281: 1309 1312.
2. Cory S., Adams J.M. (2002) The Bcl2 family: regulators of the cellular life-or-death switch. Nat Rev Cancer 2: 647 656.
3. Wang K., Yin X.M., Chao D.T., Milliman C.L., Korsmeyer S.J. (1996) BID: a novel BH3 domain-only death agonist. Genes Dev 10: 2859 2869.
4. Li H., Zhu H., Xu C.J., Yuan J. (1998) Cleavage of BID by caspase 8 mediates the mitochondrial damage in the Fas pathway of apoptosis. Cell 94: 491 501.
5. Luo X., Budihardjo I., Zou H., Slaughter C., Wang X. (1998) Bid, a Bcl2 interacting protein, mediates cytochrome c release from mitochondria in response to activation of cell surface death receptors. Cell 94: 481 490.
6. Gross A., Yin X.M., Wang K., Wei M.C., Jockel J., Milliman C., Erdjument-Bromage H., Tempst P., Korsmeyer S.J. (1999) Caspase cleaved BID targets mitochondria and is required for cytochrome c release, while BCL-XL prevents this release but not tumor necrosis factor-R1/Fas death. J Biol Chem 274: 1156 1163.
7. Chen M., He H., Zhan S., Krajewski S., Reed J.C., Gottlieb R.A. (2001) Bid is cleaved by calpain to an active fragment in vitro and during myocardial ischemia/reperfusion. J Biol Chem 276: 30724 30728.
8. Cirman T., Oresic K., Mazovec G.D., Turk V., Reed J.C., Myers R.M. et al. (2004) Selective disruption of lysosomes in HeLa cells triggers apoptosis mediated by cleavage of Bid by multiple papain-like lysosomal cathepsins. J Biol Chem 279: 3578 3587.
9. Cheng E.H., Wei M.C., Weiler S., Flavell R.A., Mak T.W., Lindsten T. et al. (2001) BCL-2, BCL-X(L) sequester BH3 domain-only molecules preventing BAX- and BAK-mediated mitochondrial apoptosis. Mol Cell 8: 705 711.
10. Scorrano L., Ashiya M., Buttle K., Weiler S., Oakes S.A., Mannella C.A. et al. (2002) A distinct pathway remodels mitochondrial cristae and mobilizes cytochrome c during apoptosis. Dev Cell 2: 55 67.
11. Eskes R., Desagher S., Antonsson B., Martinou J.C. (2000) Bid induces the oligomerization and insertion of Bax into the outer mitochondrial membrane. Mol Cell Biol 20: 929 935.
12. Korsmeyer S.J., Wei M.C., Saito M., Weiler S., Oh K.J., Schlesinger P.H. (2000) Pro-apoptotic cascade activates BID, which oligomerizes BAK or BAX into pores that result in the release of cytochrome c. Cell Death Differ 7: 1166 1173.
13. Hashimoto Y., Niikura T., Tajima H., Yasukawa T., Sudo H., Ito Y. et al. (2001) A rescue factor abolishing neuronal cell death by a wide spectrum of familial Alzheimer's disease genes and Abeta. Proc Natl Acad Sci USA 98: 6336 6341.
14. Hashimoto Y., Ito Y., Niikura T., Shao Z., Hata M., Oyama F. et al. (2001) Mechanisms of neuroprotection by a novel rescue factor humanin from Swedish mutant amyloid precursor protein. Biochem Biophys Res Commun 283: 460 468.
15. Jung S.S., Van Nostrand W.E. (2003) Humanin rescues human cerebrovascular smooth muscle cells from Abeta-induced toxicity. J Neurochem 84: 266 272.
16. Kariya S., Takahashi N., Ooba N., Kawahara M., Nakayama H., Ueno S. (2002) Humanin inhibits cell death of serum-deprived PC12h cells. Neuroreport 13: 903 907.
17. Kariya S., Takahashi N., Hirano M., Ueno S. (2003) Humanin improves impaired metabolic activity and prolongs survival of serum-deprived human lymphocytes. Mol Cell Biochem 254: 83 89.
18. Nishimoto I., Matsuoka M., niikura T. (2004) Unravelling the role of Humanin. Trends Mol Med 10: 102 105.
19. Niikura T., Chiba T., Aiso S., Matsuoka M., Nishimoto I. (2004) Humanin: after the discovery. Mol Neurobiol 30: 327 340.
20. Zhai D., Luciano F., Zhu X., Guo B., Satterthwait A.C., Reed J.C. (2005) Humanin binds and nullifies Bid activity by blocking its activation of Bax and Bak. J Biol Chem 280: 15815 15824.
21. Luciano F., Zhai D., Zhu X., Bailly-Maitre B., Ricci J.E., Satterthwait A.C. et al. (2005) Cytoprotective peptide humanin binds and inhibits proapoptotic Bcl-2/Bax family protein BimEL. J Biol Chem 280: 15825 15835.
22. Guo B., Zhai D., Cabezas E., Welsh K., Nouraini S., Satterthwait A.C. et al. (2003) Humanin peptide suppresses apoptosis by interfering with Bax activation. Nature 423: 456 461.
23. McDonnell J.M., Fushman D., Milliman C.L., Korsmeyer S.J., Cowburn D. (1999) Solution structure of the proapoptotic molecule BID: a structural basis for apoptotic agonists and antagonists. Cell 96: 625 634.
24. Chou J.J., Li H., Salvesen G.S., Yuan J., Wagner G. (1999) Solution structure of BID, an intracellular amplifier of apoptotic signaling. Cell 96: 615 624.
25. Suzuki M., Youle R.J., Tjandra N. (2000) Structure of Bax: coregulation of dimer formation and intracellular localization. Cell 103: 645 654.
26. Hinds M.G., Smits C., Fredericks-Short R., Risk J.M., Bailey M., Huang D.C. et al. (2007) Bim, Bad and Bmf: intrinsically unstructured BH3-only proteins that undergo a localized conformational change upon binding to prosurvival Bcl-2 targets. Cell Death Differ 14: 128 136.
27. Benaki D., Zikos C., Evangelou A., Livaniou E., Vlassi M., Mikros E. et al. (2005) Solution structure of humanin, a peptide against Alzheimer's disease-related neurotoxicity. Biochem Biophys Res Commun 329: 152 160.
28. Benaki D., Zikos C., Evangelou A., Livaniou E., Vlassi M., Mikros E. et al. (2006) Solution structure of Ser14Gly-humanin, a potent rescue factor against neuronal cell death in Alzheimer's disease. Biochem Biophys Res Commun 349: 634 642.
29. Arakawa T., Niikura T., Tajima H., Kita Y. (2006) The secondary structure analysis of a potent Ser14Gly analog of anti-Alzheimer peptide, Humanin, by circular dichroism. J Pept Sci 12: 639 642.
30. Schendel S.L., Azimov R., Pawlowski K., Godzik A., Kagan B.L., Reed J.C. (1999) Ion channel activity of the BH3 only Bcl-2 family member, BID. J Biol Chem 274: 21932 21936.
31. Cavanagh J. (1996) Protein NMR Spectroscopy: Principles and Practice. San Diego: Academic Press.
32. Delaglio F., Grzesiek S., Vuister G.W., Zhu G., Pfeifer J., Bax A. (1995) NMRPipe: a multidimensional spectral processing system based on UNIX pipes. J Biomol NMR 6: 277 293.
33. Goddard T.D., Kneller D.G. (2004) SPARKY 3. San Francisco: University of California.
34. Mori S., Abeygunawardana C., Johnson M.O., Vanzijl P.C.M. (1995) Improved sensitivity of HSQC spectra of exchanging protons at short interscan delays using a new fast HSQC (FHSQC) detection scheme that avoids water saturation. J Magn Reson B 108: 94 98.
35. Ikura M., Kay L.E., Bax A. (1990) A novel approach for sequential assignment of 1H, 13C, and 15N spectra of proteins: heteronuclear triple-resonance three-dimensional NMR spectroscopy. Application to calmodulin. Biochemistry 29: 4659 4667.
36. Sattler M., Schleucher J., Griesinger C. (1999) Heteronuclear multidimensional NMR experiments for the structure determination of proteins in solution employing pulsed field gradients. Prog Nucl Magn Reson Spectrosc 34: 93 158.
37. Grzesiek S., Bax A. (1992) Correlating backbone amide and side chain resonances in larger proteins by multiple relayed triple resonance NMR. J Am Chem Soc 114: 6291 6293.
38. Grzesiek S., Bax A., Clore G.M., Gronenborn A.M., Hu J.S., Kaufman J. et al. (1996) The solution structure of HIV-1 Nef reveals an unexpected fold and permits delineation of the binding surface for the SH3 domain of Hck tyrosine protein kinase. Nat Struct Biol 3: 340 345.
39. Hoffman R.M., Li M.X., Sykes B.D. (2005) The binding of w7, an inhibitor of striated muscle contraction, to cardiac troponin C. Biochemistry 44: 15750 15759.
40. Evans J.N.S. (1995) Biomolecular NMR Spectroscopy. Oxford; New York: Oxford University Press.
41. Nicholls A., Sharp K.A., Honig B. (1991) Protein folding and association: insights from the interfacial and thermodynamic properties of hydrocarbons. Proteins 11: 281 296.
42. Shuker S.B., Hajduk P.J., Meadows R.P., Fesik S.W. (1996) Discovering high-affinity ligands for proteins: SAR by NMR. Science 274: 1531 1534.
43. Rajagopal P., Waygood E.B., Klevit R.E. (1994) Structural consequences of histidine phosphorylation: NMR characterization of the phosphohistidine form of histidine-containing protein from Bacillus subtilis and Escherichia coli. Biochemistry 33: 15271 15282.
44. Chang B.S., Minn A.J., Muchmore S.W., Fesik S.W., Thompson C.B. (1997) Identification of a novel regulatory domain in Bcl-X(L) and Bcl-2. EMBO J 16: 968 977.
45. Lin B., Kolluri S.K., Lin F., Liu W., Han Y.H., Cao X. et al. (2004) Conversion of Bcl-2 from protector to killer by interaction with nuclear orphan receptor Nur77/TR3. Cell 116: 527 540.
46. Adams J.M., Cory S. (2007) The Bcl-2 apoptotic switch in cancer development and therapy. Oncogene 26: 1324 1337.
47. Muchmore S.W., Sattler M., Liang H., Meadows R.P., Harlan J.E., Yoon H.S. et al. (1996) X-ray and NMR structure of human Bcl-xL, an inhibitor of programmed cell death. Nature 381: 335 341.
48. Curran A.R., Engelman D.M. (2003) Sequence motifs, polar interactions and conformational changes in helical membrane proteins. Curr Opin Struct Biol 13: 412 417.
49. Sato T., Kienlen-Campard P., Ahmed M., Liu W., Li H., Elliott J.I. et al. (2006) Inhibitors of amyloid toxicity based on beta-sheet packing of Abeta40 and Abeta42. Biochemistry 45: 5503 5516.
50. Yin H., Slusky J.S., Berger B.W., Walters R.S., Vilaire G., Litvinov R.I. et al. (2007) Computational design of peptides that target transmembrane helices. Science 315: 1817 1822.
51. Kyte J., Doolittle R.F. (1982) A simple method for displaying the hydropathic character of a protein. J Mol Biol 157: 105 132.